 |
 |
Research news from the Cure Parkinson's Trust -- a patient led organization in the UK that advocates for and supports PD research. Dr. Gill was one of the clinical trial doctors in the original GDNF trials, and has been working on an improved delivery sytem, that hopefully will soon enter clinical trials."The Cure Parkinson’s Trust is launching a special appeal to fund a project that could have life-changing implications for those living with Parkinson’s" "Professor Steven Gill has designed a proof-of-concept clinical trial using the growth factor, GDNF. The trial has twin objectives of firstly proving the efficacy and safety of GDNF as a therapy for people with Parkinson’s and secondly, evaluating Professor Gill’s new delivery system. Glial Derived Neurotrophic Factor (GDNF) showed remarkable neurorestorative and neuroprotective effects in early trials on people with Parkinson’s. To best illustrate this, click here for a short video highlighting the trial and featuring Parkinson's advocates and the lead scientist. Since then, the work on GDNF has been held back following commercial delays, but none of these have diminished the extraordinary potential of this therapy." Read more about this exciting research and how you can help fund it at the Cure Parkinson's Trust website see: http://www.cureparkinsons.org.uk/document_1.aspx?id=0:60951&id=0:36727 ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn